VitaStem Price (VITASTEM)

The live VitaStem (VITASTEM) price today is $ 0.065531, with a 1.32% change over the past 24 hours. The current VITASTEM to USD conversion rate is $ 0.065531 per VITASTEM.
VitaStem currently ranks #- by market capitalization at $ 205,004, with a circulating supply of 3.19M VITASTEM. During the last 24 hours, VITASTEM traded between $ 0.063674 (low) and $ 0.068577 (high), reflecting market activity. Its all-time high stands at $ 0.5982, while the all-time low was $ 0.063674.
In short-term performance, VITASTEM moved +0.02% in the last hour and -15.65% over the past 7 days. Over the past day, total trading volume reached --.
The current Market Cap of VitaStem is $ 205.00K, with a 24-hour trading volume of --. The circulating supply of VITASTEM is 3.19M, with a total supply of 10000000.0. Its Fully Diluted Valuation (FDV) is $ 642.28K.
+0.02%
-1.31%
-15.65%
-15.65%
During today, the price change of VitaStem to USD was $ -0.00087353064459137.
In the past 30 days, the price change of VitaStem to USD was $ -0.0293401618.
In the past 60 days, the price change of VitaStem to USD was $ -0.0480738627.
In the past 90 days, the price change of VitaStem to USD was $ 0.
| Period | Change (USD) | Change (%) |
|---|---|---|
| Today | $ -0.00087353064459137 | -1.31% |
| 30 Days | $ -0.0293401618 | -44.77% |
| 60 Days | $ -0.0480738627 | -73.36% |
| 90 Days | $ 0 | -- |
In 2040, the price of VitaStem could potentially see a growth of 0.00%. It could reach a trading price of $ --.
VitaSTEM — The first AI-enabled longevity project and inaugural IP-Token launched by Aubrai, VitaDAO’s decentralized scientific agent. After six months of deep research on public and proprietary single-cell RNA-seq and multi-omics datasets, our scientific research team analyzed more than 850,000 human hematopoietic stem cell transcriptomes from donors aged 23–91 (both male and female). This effort uncovered 100+ high-potential rejuvenation target genes and revealed critical drivers of decline such as RhoA hyperactivation, CD38 upregulation, and CCR9 downregulation. Rather than treating HSC aging as a single defect, Aubrai recognized it as convergent damage across interconnected systems, generating a comprehensive multi-modal, five-phase rejuvenation protocol targeting transcriptional stress, metabolic dysfunction, and epigenetic drift in parallel. The agent shortlisted target genes using insights from thousands of peer-reviewed publications and private data and also optimized experimental protocols to guide in vitro and upcoming pre-clinical testing. For the first time, human researchers and AI Agents collaborate as co-scientists in the creation of pioneering scientific IP.
MEXC is the leading cryptocurrency exchange trusted by over 10 million users worldwide. It is renowned as the exchange with the widest token selection, the fastest token listings, and the lowest trading fees in the market. Join MEXC now to experience top-tier liquidity and the most competitive fees in the market!
What is the current market price of VITASTEM?
It's currently valued at ₱3.83702458518918447000, reflecting a price movement of -1.31% over the last 24 hours. Price updates reflect live aggregated market data.
How much liquidity does VitaStem have across exchanges?
With a liquidity score of --/100, VITASTEM shows stable market depth across high-volume trading venues.
What is the daily volume for VITASTEM?
Over the last 24 hours, traders exchanged ₱-- worth of VITASTEM. High trading volume contributes to tighter spreads and smoother transactions.
What is today's price range for VitaStem?
It has traded between ₱3.72829200588021138000 and ₱4.01537646272021949000, capturing the day's volatility window.
What determines accessibility and popularity of VITASTEM on global markets?
Factors include exchange listings, trading pair availability, liquidity depth, and how well-integrated VITASTEM is within the -- ecosystem.
| Time (UTC+8) | Type | Information |
|---|---|---|
| 12-20 20:20:13 | Industry Updates | Crypto Fear Index rises to 20, market remains in "Extreme Fear" state |
| 12-20 18:47:15 | Industry Updates | Total stablecoin market cap decreased slightly by 0.26% this week, remaining at historic highs |
| 12-20 12:41:47 | Industry Updates | Japan's Interest Rate Hike Lands, Triggering Crypto Market Recovery as Some Altcoins Strengthen |
| 12-19 19:26:14 | Industry Updates | Crypto Fear Index Lingers at Low Levels, Market Remains in "Extreme Fear" State |
| 12-19 15:57:20 | Industry Updates | The European Central Bank has completed preparations for the digital euro, expected to launch in the second half of 2026 |
| 12-19 14:39:50 | Industry Updates | Crypto Market Suffers Another Sharp Decline Overnight, Bitcoin Falls Below $85,000, Total Crypto Market Cap Loses $3 Trillion |
Top cryptocurrencies with market data available on MEXC
Cryptocurrency prices are subject to high market risks and price volatility. You should invest in projects and products that you are familiar with and where you understand the risks involved. You should carefully consider your investment experience, financial situation, investment objectives and risk tolerance and consult an independent financial adviser prior to making any investment. This material should not be construed as financial advice. Past performance is not a reliable indicator of future performance. The value of your investment can go down as well as up, and you may not get back the amount you invested. You are solely responsible for your investment decisions. MEXC is not responsible for any losses you may incur. For more information, please refer to our Terms of Use and Risk Warning. Please also note that data relating to the above-mentioned cryptocurrency presented here (such as its current live price) are based on third party sources. They are presented to you on an “as is'' basis and for informational purposes only, without representation or warranty of any kind. Links provided to third-party sites are also not under MEXC’s control. MEXC is not responsible for the reliability and accuracy of such third-party sites and their contents.